[go: up one dir, main page]

AR240935A2 - Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2, 5-tiadiazol y sus sales. - Google Patents

Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2, 5-tiadiazol y sus sales.

Info

Publication number
AR240935A2
AR240935A2 AR30075285A AR30075285A AR240935A2 AR 240935 A2 AR240935 A2 AR 240935A2 AR 30075285 A AR30075285 A AR 30075285A AR 30075285 A AR30075285 A AR 30075285A AR 240935 A2 AR240935 A2 AR 240935A2
Authority
AR
Argentina
Prior art keywords
thiadiazoles
histamine
diamino
substituted
receptor antagonist
Prior art date
Application number
AR30075285A
Other languages
English (en)
Other versions
AR240935A1 (es
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of AR240935A1 publication Critical patent/AR240935A1/es
Publication of AR240935A2 publication Critical patent/AR240935A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

UN PROCEDIMIENTO PARA SINTESIS DE UN COMPUESTO DE 3-AMINO-4- 2-(2- GUAMIDIOTIOZOL-4-IL)-ALQUITIO)ALQUILAMINO)1.2.5-TIADIAZOL DE FORMULA I, EN LA QUE M VALE 1 0 2, N ES UN NUMERO ENTERO DE 2 A 4, Y SUS SALES FARMACEUTICAMNETE ACEOTABLES,EL PROCESO CONSISTE EN HACER REACIONAR UN COMPUESTO DE FORMULA (II) DONDE M Y N SON LOS DEFINIDOS ANTERIORMENTE, O SUS SALES DE ADICION PUESTO R-S-R (III), ENLA QUE R ES UN GRUPO DE FORMULA (IV) A TEMPERATURAS COMPRENDIDAS ENTRE 10{C Y 50{C, EN UN DISOLVENTE ORGANICO INERTE.
AR300752A 1984-06-22 1985-06-19 Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales. AR240935A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,588 US4644006A (en) 1984-06-22 1984-06-22 Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity

Publications (2)

Publication Number Publication Date
AR240935A1 AR240935A1 (es) 1991-03-27
AR240935A2 true AR240935A2 (es) 1991-03-27

Family

ID=24498651

Family Applications (1)

Application Number Title Priority Date Filing Date
AR300752A AR240935A1 (es) 1984-06-22 1985-06-19 Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2,5-tiadiazol y sus sales.

Country Status (33)

Country Link
US (1) US4644006A (es)
JP (2) JPS6118775A (es)
KR (1) KR900004321B1 (es)
AR (1) AR240935A1 (es)
AT (1) AT390790B (es)
AU (2) AU580605B2 (es)
BE (1) BE902724A (es)
CA (2) CA1267412A (es)
CH (1) CH665210A5 (es)
CS (1) CS257276B2 (es)
DD (1) DD240889A5 (es)
DE (1) DE3522101A1 (es)
DK (1) DK282885A (es)
ES (2) ES8702902A1 (es)
FI (1) FI852405L (es)
FR (1) FR2566406B1 (es)
GB (2) GB2161157B (es)
GR (1) GR851514B (es)
HU (1) HU193992B (es)
IE (2) IE57937B1 (es)
IL (1) IL75567A0 (es)
IT (1) IT1190372B (es)
LU (1) LU85969A1 (es)
NL (1) NL8501766A (es)
NO (1) NO161856C (es)
NZ (1) NZ212403A (es)
OA (1) OA08039A (es)
PT (1) PT80684B (es)
SE (1) SE464305B (es)
SU (1) SU1537136A3 (es)
YU (2) YU45725B (es)
ZA (1) ZA854710B (es)
ZW (1) ZW10385A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018882A1 (en) * 1990-05-29 1991-12-12 Nippon Soda Co., Ltd. N-substituted heterocyclic amidine derivative
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657237A (en) * 1968-05-22 1972-04-18 Frosst & Co Charles E Process for making 1 2 5-thiadiazoles in the sinister configuration
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
EP0040696B1 (en) * 1980-04-30 1986-08-27 Merck & Co. Inc. Aminothiadiazoles as gastric secretion inhibitors
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
DE3168031D1 (en) * 1980-07-30 1985-02-14 Ici Plc Guanidine derivatives
EP0060730A3 (en) * 1981-03-18 1982-12-08 Imperial Chemical Industries Plc Bicyclic derivatives
EP0065823A1 (en) * 1981-05-13 1982-12-01 Imperial Chemical Industries Plc Heterocyclic guanidines as histamine H-2 antagonists
FR2542741B1 (fr) * 1982-03-29 1989-12-08 Bristol Myers Co 3,4-diamino-1,2,5-thiadiazoles substitues possedant une activite antagoniste du recepteur-h2 de l'histamine
US4588826A (en) * 1982-03-29 1986-05-13 Bristol-Myers Company Ethanediimidamide intermediates
US4528377A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4517366A (en) * 1982-03-29 1985-05-14 Bristol-Myers Company Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4528378A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
FI832519L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
JPS5978171A (ja) * 1982-10-26 1984-05-04 Ikeda Mohandou:Kk 複素環式化合物
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
DK282885A (da) 1985-12-23
NL8501766A (nl) 1986-01-16
NO161856C (no) 1989-10-04
YU105185A (en) 1987-12-31
US4644006A (en) 1987-02-17
HU193992B (en) 1987-12-28
OA08039A (fr) 1987-01-31
ATA185885A (de) 1989-12-15
LU85969A1 (fr) 1986-01-24
YU45725B (sh) 1992-07-20
GR851514B (es) 1985-11-25
IL75567A0 (en) 1985-10-31
CH665210A5 (de) 1988-04-29
JPS6118775A (ja) 1986-01-27
HUT42087A (en) 1987-06-29
AT390790B (de) 1990-06-25
KR900004321B1 (ko) 1990-06-22
SE8503110D0 (sv) 1985-06-20
ZW10385A1 (en) 1986-02-05
KR860000275A (ko) 1986-01-27
AU2977589A (en) 1989-06-01
GB2161157B (en) 1988-08-10
IE58261B1 (en) 1993-08-25
IT8521217A0 (it) 1985-06-20
SE464305B (sv) 1991-04-08
FR2566406B1 (fr) 1988-01-29
AU580605B2 (en) 1989-01-19
GB2161157A (en) 1986-01-08
GB8515749D0 (en) 1985-07-24
AR240935A1 (es) 1991-03-27
ES8702881A1 (es) 1987-01-16
YU102587A (en) 1988-02-29
ES8702902A1 (es) 1987-01-16
ZA854710B (en) 1986-02-26
SU1537136A3 (ru) 1990-01-15
AU4392085A (en) 1986-01-02
DK282885D0 (da) 1985-06-21
ES544409A0 (es) 1987-01-16
JPS61186369A (ja) 1986-08-20
CA1267412A (en) 1990-04-03
NO161856B (no) 1989-06-26
CS424785A2 (en) 1987-09-17
SE8503110L (sv) 1985-12-23
DE3522101A1 (de) 1986-01-02
AU614331B2 (en) 1991-08-29
CA1297875C (en) 1992-03-24
PT80684A (en) 1985-07-01
ES551506A0 (es) 1987-01-16
IE851557L (en) 1985-12-22
IE57937B1 (en) 1993-05-19
PT80684B (en) 1987-05-08
DD240889A5 (de) 1986-11-19
NZ212403A (en) 1989-04-26
FI852405L (fi) 1985-12-23
FR2566406A1 (fr) 1985-12-27
YU45822B (sh) 1992-07-20
GB8716149D0 (en) 1987-08-12
BE902724A (fr) 1985-12-23
IT1190372B (it) 1988-02-16
FI852405A0 (fi) 1985-06-17
CS257276B2 (en) 1988-04-15
GB2192884B (en) 1988-08-10
NO852519L (no) 1985-12-23
GB2192884A (en) 1988-01-27

Similar Documents

Publication Publication Date Title
ES8706673A1 (es) Un procedimiento para la preparacion de derivados de 1,4-dihidro-4-oxonaftiridina y sus sales
NO862618D0 (no) Nye pikolinderivater, fremgangsmaate ved fremstilling derav, anvendelse og medikamenter som inneholder dem.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
SE8302693D0 (sv) Heterocyclische verbindungen
KR910009640A (ko) 헤테로고리옥시 페녹시아세트산유도체 및 제초제로서의 그의 용도
ES2060616T3 (es) Sales organicas de derivados de fisostigmina.
NO179710C (no) Nye fosfolipidderivater av nukleosider, og legemiddel inneholdende disse
ES8602022A1 (es) Un procedimiento para preparar un derivado de 4'-dimetil-4-epipodofilotoxina
ES8506612A1 (es) Un metodo para producir un derivado de amina
ES2072263T3 (es) Derivados de 4-aminopiridina.
MA19996A1 (fr) Procede de preparation de derives disubstitues de la proline
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2012736A6 (es) Procedimiento para la preparacion de derivados triciclicos de 3-oxopropanonitrilo.
ES2055026T3 (es) Derivados de cicloalcanoles sustituidos con azol, un procedimiento para producirlos y un uso de los derivados como un fungicida agricola y horticola.
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
AR240935A2 (es) Procedimiento para preparar compuestos de 3-amino-4 2-(2-guanidinotiazol-4-il)-alquiltio) alquilamino-1,2, 5-tiadiazol y sus sales.
ES2128554T3 (es) Nuevos derivados del acido glutamico, procedimiento para su preparacion y su utilizacion como medicamentos para el aumento de la memoria y aprendizaje.
ES2030080T3 (es) Procedimiento para la produccion de nuevos derivados de azol y fungicidas agricolas/horticolas que los contienen.
ES2003201A6 (es) Un procedimiento para la preparacion de esteroides aminoglicosidicos.
ES8401962A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
SE7703868L (sv) Pyridinderivat
GB1136919A (en) Amines
ES8504137A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.(como desglose y con prioridad de la patente espanola n 504.787, presentada el 17 de agosto de 1981)
UA26443A (uk) Похідhі 20,21-диhоребурhамеhіhу, їх рацемати або оптичhі ізомери, або їх адитивhі солі з оргаhічhими кислотами, що мають hоотропhі та аhтидепресивhі властивості